Global Age-related Macular Degeneration Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Age-related Macular Degeneration market size was valued at US$ 7557.7 million in 2023. With growing demand in downstream market, the Age-related Macular Degeneration is forecast to a readjusted size of US$ 11380 million by 2030 with a CAGR of 6.0% during review period.
The research report highlights the growth potential of the global Age-related Macular Degeneration market. Age-related Macular Degeneration are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Age-related Macular Degeneration. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Age-related Macular Degeneration market.
Key Features:
The report on Age-related Macular Degeneration market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Age-related Macular Degeneration market. It may include historical data, market segmentation by Type (e.g., Wet AMD, Dry AMD), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Age-related Macular Degeneration market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Age-related Macular Degeneration market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Age-related Macular Degeneration industry. This include advancements in Age-related Macular Degeneration technology, Age-related Macular Degeneration new entrants, Age-related Macular Degeneration new investment, and other innovations that are shaping the future of Age-related Macular Degeneration.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Age-related Macular Degeneration market. It includes factors influencing customer ' purchasing decisions, preferences for Age-related Macular Degeneration product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Age-related Macular Degeneration market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Age-related Macular Degeneration market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Age-related Macular Degeneration market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Age-related Macular Degeneration industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Age-related Macular Degeneration market.
Market Segmentation:
Age-related Macular Degeneration market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Age-related Macular Degeneration market size was valued at US$ 7557.7 million in 2023. With growing demand in downstream market, the Age-related Macular Degeneration is forecast to a readjusted size of US$ 11380 million by 2030 with a CAGR of 6.0% during review period.
The research report highlights the growth potential of the global Age-related Macular Degeneration market. Age-related Macular Degeneration are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Age-related Macular Degeneration. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Age-related Macular Degeneration market.
Key Features:
The report on Age-related Macular Degeneration market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Age-related Macular Degeneration market. It may include historical data, market segmentation by Type (e.g., Wet AMD, Dry AMD), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Age-related Macular Degeneration market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Age-related Macular Degeneration market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Age-related Macular Degeneration industry. This include advancements in Age-related Macular Degeneration technology, Age-related Macular Degeneration new entrants, Age-related Macular Degeneration new investment, and other innovations that are shaping the future of Age-related Macular Degeneration.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Age-related Macular Degeneration market. It includes factors influencing customer ' purchasing decisions, preferences for Age-related Macular Degeneration product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Age-related Macular Degeneration market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Age-related Macular Degeneration market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Age-related Macular Degeneration market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Age-related Macular Degeneration industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Age-related Macular Degeneration market.
Market Segmentation:
Age-related Macular Degeneration market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Wet AMD
- Dry AMD
- Drugstore
- Hospital
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer HealthCare
- F. Hoffmann-La Roche
- Novartis
- Regeneron Pharmaceuticals
- Alcon
- Allergan
- Avalanche
- Bausch+Lomb
- Gilead Sciences
- Iconic Therapeutics
- Neurotech Pharmaceuticals
- Ohr Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Age-related Macular Degeneration Market Size 2019-2030
2.1.2 Age-related Macular Degeneration Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Age-related Macular Degeneration Segment by Type
2.2.1 Wet AMD
2.2.2 Dry AMD
2.3 Age-related Macular Degeneration Market Size by Type
2.3.1 Age-related Macular Degeneration Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Age-related Macular Degeneration Market Size Market Share by Type (2019-2024)
2.4 Age-related Macular Degeneration Segment by Application
2.4.1 Drugstore
2.4.2 Hospital
2.4.3 Others
2.5 Age-related Macular Degeneration Market Size by Application
2.5.1 Age-related Macular Degeneration Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Age-related Macular Degeneration Market Size Market Share by Application (2019-2024)
3 AGE-RELATED MACULAR DEGENERATION MARKET SIZE BY PLAYER
3.1 Age-related Macular Degeneration Market Size Market Share by Players
3.1.1 Global Age-related Macular Degeneration Revenue by Players (2019-2024)
3.1.2 Global Age-related Macular Degeneration Revenue Market Share by Players (2019-2024)
3.2 Global Age-related Macular Degeneration Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AGE-RELATED MACULAR DEGENERATION BY REGIONS
4.1 Age-related Macular Degeneration Market Size by Regions (2019-2024)
4.2 Americas Age-related Macular Degeneration Market Size Growth (2019-2024)
4.3 APAC Age-related Macular Degeneration Market Size Growth (2019-2024)
4.4 Europe Age-related Macular Degeneration Market Size Growth (2019-2024)
4.5 Middle East & Africa Age-related Macular Degeneration Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Age-related Macular Degeneration Market Size by Country (2019-2024)
5.2 Americas Age-related Macular Degeneration Market Size by Type (2019-2024)
5.3 Americas Age-related Macular Degeneration Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Age-related Macular Degeneration Market Size by Region (2019-2024)
6.2 APAC Age-related Macular Degeneration Market Size by Type (2019-2024)
6.3 APAC Age-related Macular Degeneration Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Age-related Macular Degeneration by Country (2019-2024)
7.2 Europe Age-related Macular Degeneration Market Size by Type (2019-2024)
7.3 Europe Age-related Macular Degeneration Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Age-related Macular Degeneration by Region (2019-2024)
8.2 Middle East & Africa Age-related Macular Degeneration Market Size by Type (2019-2024)
8.3 Middle East & Africa Age-related Macular Degeneration Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET FORECAST
10.1 Global Age-related Macular Degeneration Forecast by Regions (2025-2030)
10.1.1 Global Age-related Macular Degeneration Forecast by Regions (2025-2030)
10.1.2 Americas Age-related Macular Degeneration Forecast
10.1.3 APAC Age-related Macular Degeneration Forecast
10.1.4 Europe Age-related Macular Degeneration Forecast
10.1.5 Middle East & Africa Age-related Macular Degeneration Forecast
10.2 Americas Age-related Macular Degeneration Forecast by Country (2025-2030)
10.2.1 United States Age-related Macular Degeneration Market Forecast
10.2.2 Canada Age-related Macular Degeneration Market Forecast
10.2.3 Mexico Age-related Macular Degeneration Market Forecast
10.2.4 Brazil Age-related Macular Degeneration Market Forecast
10.3 APAC Age-related Macular Degeneration Forecast by Region (2025-2030)
10.3.1 China Age-related Macular Degeneration Market Forecast
10.3.2 Japan Age-related Macular Degeneration Market Forecast
10.3.3 Korea Age-related Macular Degeneration Market Forecast
10.3.4 Southeast Asia Age-related Macular Degeneration Market Forecast
10.3.5 India Age-related Macular Degeneration Market Forecast
10.3.6 Australia Age-related Macular Degeneration Market Forecast
10.4 Europe Age-related Macular Degeneration Forecast by Country (2025-2030)
10.4.1 Germany Age-related Macular Degeneration Market Forecast
10.4.2 France Age-related Macular Degeneration Market Forecast
10.4.3 UK Age-related Macular Degeneration Market Forecast
10.4.4 Italy Age-related Macular Degeneration Market Forecast
10.4.5 Russia Age-related Macular Degeneration Market Forecast
10.5 Middle East & Africa Age-related Macular Degeneration Forecast by Region (2025-2030)
10.5.1 Egypt Age-related Macular Degeneration Market Forecast
10.5.2 South Africa Age-related Macular Degeneration Market Forecast
10.5.3 Israel Age-related Macular Degeneration Market Forecast
10.5.4 Turkey Age-related Macular Degeneration Market Forecast
10.5.5 GCC Countries Age-related Macular Degeneration Market Forecast
10.6 Global Age-related Macular Degeneration Forecast by Type (2025-2030)
10.7 Global Age-related Macular Degeneration Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Bayer HealthCare
11.1.1 Bayer HealthCare Company Information
11.1.2 Bayer HealthCare Age-related Macular Degeneration Product Offered
11.1.3 Bayer HealthCare Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bayer HealthCare Main Business Overview
11.1.5 Bayer HealthCare Latest Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Information
11.2.2 F. Hoffmann-La Roche Age-related Macular Degeneration Product Offered
11.2.3 F. Hoffmann-La Roche Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 F. Hoffmann-La Roche Main Business Overview
11.2.5 F. Hoffmann-La Roche Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Age-related Macular Degeneration Product Offered
11.3.3 Novartis Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Regeneron Pharmaceuticals
11.4.1 Regeneron Pharmaceuticals Company Information
11.4.2 Regeneron Pharmaceuticals Age-related Macular Degeneration Product Offered
11.4.3 Regeneron Pharmaceuticals Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Regeneron Pharmaceuticals Main Business Overview
11.4.5 Regeneron Pharmaceuticals Latest Developments
11.5 Alcon
11.5.1 Alcon Company Information
11.5.2 Alcon Age-related Macular Degeneration Product Offered
11.5.3 Alcon Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Alcon Main Business Overview
11.5.5 Alcon Latest Developments
11.6 Allergan
11.6.1 Allergan Company Information
11.6.2 Allergan Age-related Macular Degeneration Product Offered
11.6.3 Allergan Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Allergan Main Business Overview
11.6.5 Allergan Latest Developments
11.7 Avalanche
11.7.1 Avalanche Company Information
11.7.2 Avalanche Age-related Macular Degeneration Product Offered
11.7.3 Avalanche Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Avalanche Main Business Overview
11.7.5 Avalanche Latest Developments
11.8 Bausch+Lomb
11.8.1 Bausch+Lomb Company Information
11.8.2 Bausch+Lomb Age-related Macular Degeneration Product Offered
11.8.3 Bausch+Lomb Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Bausch+Lomb Main Business Overview
11.8.5 Bausch+Lomb Latest Developments
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Information
11.9.2 Gilead Sciences Age-related Macular Degeneration Product Offered
11.9.3 Gilead Sciences Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Gilead Sciences Main Business Overview
11.9.5 Gilead Sciences Latest Developments
11.10 Iconic Therapeutics
11.10.1 Iconic Therapeutics Company Information
11.10.2 Iconic Therapeutics Age-related Macular Degeneration Product Offered
11.10.3 Iconic Therapeutics Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Iconic Therapeutics Main Business Overview
11.10.5 Iconic Therapeutics Latest Developments
11.11 Neurotech Pharmaceuticals
11.11.1 Neurotech Pharmaceuticals Company Information
11.11.2 Neurotech Pharmaceuticals Age-related Macular Degeneration Product Offered
11.11.3 Neurotech Pharmaceuticals Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Neurotech Pharmaceuticals Main Business Overview
11.11.5 Neurotech Pharmaceuticals Latest Developments
11.12 Ohr Pharmaceutical
11.12.1 Ohr Pharmaceutical Company Information
11.12.2 Ohr Pharmaceutical Age-related Macular Degeneration Product Offered
11.12.3 Ohr Pharmaceutical Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Ohr Pharmaceutical Main Business Overview
11.12.5 Ohr Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Age-related Macular Degeneration Market Size 2019-2030
2.1.2 Age-related Macular Degeneration Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Age-related Macular Degeneration Segment by Type
2.2.1 Wet AMD
2.2.2 Dry AMD
2.3 Age-related Macular Degeneration Market Size by Type
2.3.1 Age-related Macular Degeneration Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Age-related Macular Degeneration Market Size Market Share by Type (2019-2024)
2.4 Age-related Macular Degeneration Segment by Application
2.4.1 Drugstore
2.4.2 Hospital
2.4.3 Others
2.5 Age-related Macular Degeneration Market Size by Application
2.5.1 Age-related Macular Degeneration Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Age-related Macular Degeneration Market Size Market Share by Application (2019-2024)
3 AGE-RELATED MACULAR DEGENERATION MARKET SIZE BY PLAYER
3.1 Age-related Macular Degeneration Market Size Market Share by Players
3.1.1 Global Age-related Macular Degeneration Revenue by Players (2019-2024)
3.1.2 Global Age-related Macular Degeneration Revenue Market Share by Players (2019-2024)
3.2 Global Age-related Macular Degeneration Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AGE-RELATED MACULAR DEGENERATION BY REGIONS
4.1 Age-related Macular Degeneration Market Size by Regions (2019-2024)
4.2 Americas Age-related Macular Degeneration Market Size Growth (2019-2024)
4.3 APAC Age-related Macular Degeneration Market Size Growth (2019-2024)
4.4 Europe Age-related Macular Degeneration Market Size Growth (2019-2024)
4.5 Middle East & Africa Age-related Macular Degeneration Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Age-related Macular Degeneration Market Size by Country (2019-2024)
5.2 Americas Age-related Macular Degeneration Market Size by Type (2019-2024)
5.3 Americas Age-related Macular Degeneration Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Age-related Macular Degeneration Market Size by Region (2019-2024)
6.2 APAC Age-related Macular Degeneration Market Size by Type (2019-2024)
6.3 APAC Age-related Macular Degeneration Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Age-related Macular Degeneration by Country (2019-2024)
7.2 Europe Age-related Macular Degeneration Market Size by Type (2019-2024)
7.3 Europe Age-related Macular Degeneration Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Age-related Macular Degeneration by Region (2019-2024)
8.2 Middle East & Africa Age-related Macular Degeneration Market Size by Type (2019-2024)
8.3 Middle East & Africa Age-related Macular Degeneration Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET FORECAST
10.1 Global Age-related Macular Degeneration Forecast by Regions (2025-2030)
10.1.1 Global Age-related Macular Degeneration Forecast by Regions (2025-2030)
10.1.2 Americas Age-related Macular Degeneration Forecast
10.1.3 APAC Age-related Macular Degeneration Forecast
10.1.4 Europe Age-related Macular Degeneration Forecast
10.1.5 Middle East & Africa Age-related Macular Degeneration Forecast
10.2 Americas Age-related Macular Degeneration Forecast by Country (2025-2030)
10.2.1 United States Age-related Macular Degeneration Market Forecast
10.2.2 Canada Age-related Macular Degeneration Market Forecast
10.2.3 Mexico Age-related Macular Degeneration Market Forecast
10.2.4 Brazil Age-related Macular Degeneration Market Forecast
10.3 APAC Age-related Macular Degeneration Forecast by Region (2025-2030)
10.3.1 China Age-related Macular Degeneration Market Forecast
10.3.2 Japan Age-related Macular Degeneration Market Forecast
10.3.3 Korea Age-related Macular Degeneration Market Forecast
10.3.4 Southeast Asia Age-related Macular Degeneration Market Forecast
10.3.5 India Age-related Macular Degeneration Market Forecast
10.3.6 Australia Age-related Macular Degeneration Market Forecast
10.4 Europe Age-related Macular Degeneration Forecast by Country (2025-2030)
10.4.1 Germany Age-related Macular Degeneration Market Forecast
10.4.2 France Age-related Macular Degeneration Market Forecast
10.4.3 UK Age-related Macular Degeneration Market Forecast
10.4.4 Italy Age-related Macular Degeneration Market Forecast
10.4.5 Russia Age-related Macular Degeneration Market Forecast
10.5 Middle East & Africa Age-related Macular Degeneration Forecast by Region (2025-2030)
10.5.1 Egypt Age-related Macular Degeneration Market Forecast
10.5.2 South Africa Age-related Macular Degeneration Market Forecast
10.5.3 Israel Age-related Macular Degeneration Market Forecast
10.5.4 Turkey Age-related Macular Degeneration Market Forecast
10.5.5 GCC Countries Age-related Macular Degeneration Market Forecast
10.6 Global Age-related Macular Degeneration Forecast by Type (2025-2030)
10.7 Global Age-related Macular Degeneration Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Bayer HealthCare
11.1.1 Bayer HealthCare Company Information
11.1.2 Bayer HealthCare Age-related Macular Degeneration Product Offered
11.1.3 Bayer HealthCare Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bayer HealthCare Main Business Overview
11.1.5 Bayer HealthCare Latest Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Information
11.2.2 F. Hoffmann-La Roche Age-related Macular Degeneration Product Offered
11.2.3 F. Hoffmann-La Roche Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 F. Hoffmann-La Roche Main Business Overview
11.2.5 F. Hoffmann-La Roche Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Age-related Macular Degeneration Product Offered
11.3.3 Novartis Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Regeneron Pharmaceuticals
11.4.1 Regeneron Pharmaceuticals Company Information
11.4.2 Regeneron Pharmaceuticals Age-related Macular Degeneration Product Offered
11.4.3 Regeneron Pharmaceuticals Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Regeneron Pharmaceuticals Main Business Overview
11.4.5 Regeneron Pharmaceuticals Latest Developments
11.5 Alcon
11.5.1 Alcon Company Information
11.5.2 Alcon Age-related Macular Degeneration Product Offered
11.5.3 Alcon Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Alcon Main Business Overview
11.5.5 Alcon Latest Developments
11.6 Allergan
11.6.1 Allergan Company Information
11.6.2 Allergan Age-related Macular Degeneration Product Offered
11.6.3 Allergan Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Allergan Main Business Overview
11.6.5 Allergan Latest Developments
11.7 Avalanche
11.7.1 Avalanche Company Information
11.7.2 Avalanche Age-related Macular Degeneration Product Offered
11.7.3 Avalanche Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Avalanche Main Business Overview
11.7.5 Avalanche Latest Developments
11.8 Bausch+Lomb
11.8.1 Bausch+Lomb Company Information
11.8.2 Bausch+Lomb Age-related Macular Degeneration Product Offered
11.8.3 Bausch+Lomb Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Bausch+Lomb Main Business Overview
11.8.5 Bausch+Lomb Latest Developments
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Information
11.9.2 Gilead Sciences Age-related Macular Degeneration Product Offered
11.9.3 Gilead Sciences Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Gilead Sciences Main Business Overview
11.9.5 Gilead Sciences Latest Developments
11.10 Iconic Therapeutics
11.10.1 Iconic Therapeutics Company Information
11.10.2 Iconic Therapeutics Age-related Macular Degeneration Product Offered
11.10.3 Iconic Therapeutics Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Iconic Therapeutics Main Business Overview
11.10.5 Iconic Therapeutics Latest Developments
11.11 Neurotech Pharmaceuticals
11.11.1 Neurotech Pharmaceuticals Company Information
11.11.2 Neurotech Pharmaceuticals Age-related Macular Degeneration Product Offered
11.11.3 Neurotech Pharmaceuticals Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Neurotech Pharmaceuticals Main Business Overview
11.11.5 Neurotech Pharmaceuticals Latest Developments
11.12 Ohr Pharmaceutical
11.12.1 Ohr Pharmaceutical Company Information
11.12.2 Ohr Pharmaceutical Age-related Macular Degeneration Product Offered
11.12.3 Ohr Pharmaceutical Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Ohr Pharmaceutical Main Business Overview
11.12.5 Ohr Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Age-related Macular Degeneration Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Wet AMD
Table 3. Major Players of Dry AMD
Table 4. Age-related Macular Degeneration Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Age-related Macular Degeneration Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Age-related Macular Degeneration Market Size Market Share by Type (2019-2024)
Table 7. Age-related Macular Degeneration Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Age-related Macular Degeneration Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Age-related Macular Degeneration Market Size Market Share by Application (2019-2024)
Table 10. Global Age-related Macular Degeneration Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Age-related Macular Degeneration Revenue Market Share by Player (2019-2024)
Table 12. Age-related Macular Degeneration Key Players Head office and Products Offered
Table 13. Age-related Macular Degeneration Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Age-related Macular Degeneration Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Age-related Macular Degeneration Market Size Market Share by Regions (2019-2024)
Table 18. Global Age-related Macular Degeneration Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Age-related Macular Degeneration Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Age-related Macular Degeneration Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Age-related Macular Degeneration Market Size Market Share by Country (2019-2024)
Table 22. Americas Age-related Macular Degeneration Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Age-related Macular Degeneration Market Size Market Share by Type (2019-2024)
Table 24. Americas Age-related Macular Degeneration Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Age-related Macular Degeneration Market Size Market Share by Application (2019-2024)
Table 26. APAC Age-related Macular Degeneration Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Age-related Macular Degeneration Market Size Market Share by Region (2019-2024)
Table 28. APAC Age-related Macular Degeneration Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Age-related Macular Degeneration Market Size Market Share by Type (2019-2024)
Table 30. APAC Age-related Macular Degeneration Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Age-related Macular Degeneration Market Size Market Share by Application (2019-2024)
Table 32. Europe Age-related Macular Degeneration Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Age-related Macular Degeneration Market Size Market Share by Country (2019-2024)
Table 34. Europe Age-related Macular Degeneration Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Age-related Macular Degeneration Market Size Market Share by Type (2019-2024)
Table 36. Europe Age-related Macular Degeneration Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Age-related Macular Degeneration Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Age-related Macular Degeneration Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Age-related Macular Degeneration Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Age-related Macular Degeneration Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Age-related Macular Degeneration Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Age-related Macular Degeneration Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Age-related Macular Degeneration Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Age-related Macular Degeneration
Table 45. Key Market Challenges & Risks of Age-related Macular Degeneration
Table 46. Key Industry Trends of Age-related Macular Degeneration
Table 47. Global Age-related Macular Degeneration Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Age-related Macular Degeneration Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Age-related Macular Degeneration Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Age-related Macular Degeneration Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Bayer HealthCare Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 52. Bayer HealthCare Age-related Macular Degeneration Product Offered
Table 53. Bayer HealthCare Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Bayer HealthCare Main Business
Table 55. Bayer HealthCare Latest Developments
Table 56. F. Hoffmann-La Roche Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 57. F. Hoffmann-La Roche Age-related Macular Degeneration Product Offered
Table 58. F. Hoffmann-La Roche Main Business
Table 59. F. Hoffmann-La Roche Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. F. Hoffmann-La Roche Latest Developments
Table 61. Novartis Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 62. Novartis Age-related Macular Degeneration Product Offered
Table 63. Novartis Main Business
Table 64. Novartis Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Novartis Latest Developments
Table 66. Regeneron Pharmaceuticals Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 67. Regeneron Pharmaceuticals Age-related Macular Degeneration Product Offered
Table 68. Regeneron Pharmaceuticals Main Business
Table 69. Regeneron Pharmaceuticals Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Regeneron Pharmaceuticals Latest Developments
Table 71. Alcon Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 72. Alcon Age-related Macular Degeneration Product Offered
Table 73. Alcon Main Business
Table 74. Alcon Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Alcon Latest Developments
Table 76. Allergan Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 77. Allergan Age-related Macular Degeneration Product Offered
Table 78. Allergan Main Business
Table 79. Allergan Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Allergan Latest Developments
Table 81. Avalanche Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 82. Avalanche Age-related Macular Degeneration Product Offered
Table 83. Avalanche Main Business
Table 84. Avalanche Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Avalanche Latest Developments
Table 86. Bausch+Lomb Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 87. Bausch+Lomb Age-related Macular Degeneration Product Offered
Table 88. Bausch+Lomb Main Business
Table 89. Bausch+Lomb Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Bausch+Lomb Latest Developments
Table 91. Gilead Sciences Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 92. Gilead Sciences Age-related Macular Degeneration Product Offered
Table 93. Gilead Sciences Main Business
Table 94. Gilead Sciences Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Gilead Sciences Latest Developments
Table 96. Iconic Therapeutics Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 97. Iconic Therapeutics Age-related Macular Degeneration Product Offered
Table 98. Iconic Therapeutics Main Business
Table 99. Iconic Therapeutics Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Iconic Therapeutics Latest Developments
Table 101. Neurotech Pharmaceuticals Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 102. Neurotech Pharmaceuticals Age-related Macular Degeneration Product Offered
Table 103. Neurotech Pharmaceuticals Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Neurotech Pharmaceuticals Main Business
Table 105. Neurotech Pharmaceuticals Latest Developments
Table 106. Ohr Pharmaceutical Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 107. Ohr Pharmaceutical Age-related Macular Degeneration Product Offered
Table 108. Ohr Pharmaceutical Main Business
Table 109. Ohr Pharmaceutical Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Ohr Pharmaceutical Latest Developments
Table 1. Age-related Macular Degeneration Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Wet AMD
Table 3. Major Players of Dry AMD
Table 4. Age-related Macular Degeneration Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Age-related Macular Degeneration Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Age-related Macular Degeneration Market Size Market Share by Type (2019-2024)
Table 7. Age-related Macular Degeneration Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Age-related Macular Degeneration Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Age-related Macular Degeneration Market Size Market Share by Application (2019-2024)
Table 10. Global Age-related Macular Degeneration Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Age-related Macular Degeneration Revenue Market Share by Player (2019-2024)
Table 12. Age-related Macular Degeneration Key Players Head office and Products Offered
Table 13. Age-related Macular Degeneration Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Age-related Macular Degeneration Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Age-related Macular Degeneration Market Size Market Share by Regions (2019-2024)
Table 18. Global Age-related Macular Degeneration Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Age-related Macular Degeneration Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Age-related Macular Degeneration Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Age-related Macular Degeneration Market Size Market Share by Country (2019-2024)
Table 22. Americas Age-related Macular Degeneration Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Age-related Macular Degeneration Market Size Market Share by Type (2019-2024)
Table 24. Americas Age-related Macular Degeneration Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Age-related Macular Degeneration Market Size Market Share by Application (2019-2024)
Table 26. APAC Age-related Macular Degeneration Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Age-related Macular Degeneration Market Size Market Share by Region (2019-2024)
Table 28. APAC Age-related Macular Degeneration Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Age-related Macular Degeneration Market Size Market Share by Type (2019-2024)
Table 30. APAC Age-related Macular Degeneration Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Age-related Macular Degeneration Market Size Market Share by Application (2019-2024)
Table 32. Europe Age-related Macular Degeneration Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Age-related Macular Degeneration Market Size Market Share by Country (2019-2024)
Table 34. Europe Age-related Macular Degeneration Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Age-related Macular Degeneration Market Size Market Share by Type (2019-2024)
Table 36. Europe Age-related Macular Degeneration Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Age-related Macular Degeneration Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Age-related Macular Degeneration Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Age-related Macular Degeneration Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Age-related Macular Degeneration Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Age-related Macular Degeneration Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Age-related Macular Degeneration Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Age-related Macular Degeneration Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Age-related Macular Degeneration
Table 45. Key Market Challenges & Risks of Age-related Macular Degeneration
Table 46. Key Industry Trends of Age-related Macular Degeneration
Table 47. Global Age-related Macular Degeneration Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Age-related Macular Degeneration Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Age-related Macular Degeneration Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Age-related Macular Degeneration Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Bayer HealthCare Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 52. Bayer HealthCare Age-related Macular Degeneration Product Offered
Table 53. Bayer HealthCare Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Bayer HealthCare Main Business
Table 55. Bayer HealthCare Latest Developments
Table 56. F. Hoffmann-La Roche Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 57. F. Hoffmann-La Roche Age-related Macular Degeneration Product Offered
Table 58. F. Hoffmann-La Roche Main Business
Table 59. F. Hoffmann-La Roche Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. F. Hoffmann-La Roche Latest Developments
Table 61. Novartis Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 62. Novartis Age-related Macular Degeneration Product Offered
Table 63. Novartis Main Business
Table 64. Novartis Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Novartis Latest Developments
Table 66. Regeneron Pharmaceuticals Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 67. Regeneron Pharmaceuticals Age-related Macular Degeneration Product Offered
Table 68. Regeneron Pharmaceuticals Main Business
Table 69. Regeneron Pharmaceuticals Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Regeneron Pharmaceuticals Latest Developments
Table 71. Alcon Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 72. Alcon Age-related Macular Degeneration Product Offered
Table 73. Alcon Main Business
Table 74. Alcon Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Alcon Latest Developments
Table 76. Allergan Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 77. Allergan Age-related Macular Degeneration Product Offered
Table 78. Allergan Main Business
Table 79. Allergan Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Allergan Latest Developments
Table 81. Avalanche Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 82. Avalanche Age-related Macular Degeneration Product Offered
Table 83. Avalanche Main Business
Table 84. Avalanche Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Avalanche Latest Developments
Table 86. Bausch+Lomb Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 87. Bausch+Lomb Age-related Macular Degeneration Product Offered
Table 88. Bausch+Lomb Main Business
Table 89. Bausch+Lomb Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Bausch+Lomb Latest Developments
Table 91. Gilead Sciences Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 92. Gilead Sciences Age-related Macular Degeneration Product Offered
Table 93. Gilead Sciences Main Business
Table 94. Gilead Sciences Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Gilead Sciences Latest Developments
Table 96. Iconic Therapeutics Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 97. Iconic Therapeutics Age-related Macular Degeneration Product Offered
Table 98. Iconic Therapeutics Main Business
Table 99. Iconic Therapeutics Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Iconic Therapeutics Latest Developments
Table 101. Neurotech Pharmaceuticals Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 102. Neurotech Pharmaceuticals Age-related Macular Degeneration Product Offered
Table 103. Neurotech Pharmaceuticals Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Neurotech Pharmaceuticals Main Business
Table 105. Neurotech Pharmaceuticals Latest Developments
Table 106. Ohr Pharmaceutical Details, Company Type, Age-related Macular Degeneration Area Served and Its Competitors
Table 107. Ohr Pharmaceutical Age-related Macular Degeneration Product Offered
Table 108. Ohr Pharmaceutical Main Business
Table 109. Ohr Pharmaceutical Age-related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Ohr Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Age-related Macular Degeneration Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Age-related Macular Degeneration Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Age-related Macular Degeneration Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Age-related Macular Degeneration Sales Market Share by Country/Region (2023)
Figure 8. Age-related Macular Degeneration Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Age-related Macular Degeneration Market Size Market Share by Type in 2023
Figure 10. Age-related Macular Degeneration in Drugstore
Figure 11. Global Age-related Macular Degeneration Market: Drugstore (2019-2024) & ($ Millions)
Figure 12. Age-related Macular Degeneration in Hospital
Figure 13. Global Age-related Macular Degeneration Market: Hospital (2019-2024) & ($ Millions)
Figure 14. Age-related Macular Degeneration in Others
Figure 15. Global Age-related Macular Degeneration Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Age-related Macular Degeneration Market Size Market Share by Application in 2023
Figure 17. Global Age-related Macular Degeneration Revenue Market Share by Player in 2023
Figure 18. Global Age-related Macular Degeneration Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Age-related Macular Degeneration Market Size 2019-2024 ($ Millions)
Figure 20. APAC Age-related Macular Degeneration Market Size 2019-2024 ($ Millions)
Figure 21. Europe Age-related Macular Degeneration Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Age-related Macular Degeneration Market Size 2019-2024 ($ Millions)
Figure 23. Americas Age-related Macular Degeneration Value Market Share by Country in 2023
Figure 24. United States Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Age-related Macular Degeneration Market Size Market Share by Region in 2023
Figure 29. APAC Age-related Macular Degeneration Market Size Market Share by Type in 2023
Figure 30. APAC Age-related Macular Degeneration Market Size Market Share by Application in 2023
Figure 31. China Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Age-related Macular Degeneration Market Size Market Share by Country in 2023
Figure 38. Europe Age-related Macular Degeneration Market Size Market Share by Type (2019-2024)
Figure 39. Europe Age-related Macular Degeneration Market Size Market Share by Application (2019-2024)
Figure 40. Germany Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Age-related Macular Degeneration Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Age-related Macular Degeneration Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Age-related Macular Degeneration Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 54. APAC Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 55. Europe Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 57. United States Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 58. Canada Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 61. China Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 62. Japan Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 63. Korea Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 65. India Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 66. Australia Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 67. Germany Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 68. France Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 69. UK Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 70. Italy Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 71. Russia Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 72. Spain Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 75. Israel Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 78. Global Age-related Macular Degeneration Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Age-related Macular Degeneration Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Age-related Macular Degeneration Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Age-related Macular Degeneration Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Age-related Macular Degeneration Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Age-related Macular Degeneration Sales Market Share by Country/Region (2023)
Figure 8. Age-related Macular Degeneration Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Age-related Macular Degeneration Market Size Market Share by Type in 2023
Figure 10. Age-related Macular Degeneration in Drugstore
Figure 11. Global Age-related Macular Degeneration Market: Drugstore (2019-2024) & ($ Millions)
Figure 12. Age-related Macular Degeneration in Hospital
Figure 13. Global Age-related Macular Degeneration Market: Hospital (2019-2024) & ($ Millions)
Figure 14. Age-related Macular Degeneration in Others
Figure 15. Global Age-related Macular Degeneration Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Age-related Macular Degeneration Market Size Market Share by Application in 2023
Figure 17. Global Age-related Macular Degeneration Revenue Market Share by Player in 2023
Figure 18. Global Age-related Macular Degeneration Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Age-related Macular Degeneration Market Size 2019-2024 ($ Millions)
Figure 20. APAC Age-related Macular Degeneration Market Size 2019-2024 ($ Millions)
Figure 21. Europe Age-related Macular Degeneration Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Age-related Macular Degeneration Market Size 2019-2024 ($ Millions)
Figure 23. Americas Age-related Macular Degeneration Value Market Share by Country in 2023
Figure 24. United States Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Age-related Macular Degeneration Market Size Market Share by Region in 2023
Figure 29. APAC Age-related Macular Degeneration Market Size Market Share by Type in 2023
Figure 30. APAC Age-related Macular Degeneration Market Size Market Share by Application in 2023
Figure 31. China Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Age-related Macular Degeneration Market Size Market Share by Country in 2023
Figure 38. Europe Age-related Macular Degeneration Market Size Market Share by Type (2019-2024)
Figure 39. Europe Age-related Macular Degeneration Market Size Market Share by Application (2019-2024)
Figure 40. Germany Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Age-related Macular Degeneration Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Age-related Macular Degeneration Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Age-related Macular Degeneration Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Age-related Macular Degeneration Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 54. APAC Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 55. Europe Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 57. United States Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 58. Canada Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 61. China Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 62. Japan Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 63. Korea Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 65. India Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 66. Australia Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 67. Germany Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 68. France Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 69. UK Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 70. Italy Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 71. Russia Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 72. Spain Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 75. Israel Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Age-related Macular Degeneration Market Size 2025-2030 ($ Millions)
Figure 78. Global Age-related Macular Degeneration Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Age-related Macular Degeneration Market Size Market Share Forecast by Application (2025-2030)
